BriaCell Therapeutics Corp. (BCTX): Net Income

Annual figures by period end, from SEC filings.

-$34.90M
Year ended 2026-07-31
2021-07-31: -$13.82M2022-07-31: -$26.84M2023-07-31: -$20.30M2024-07-31: -$4.79M2025-07-31: -$26.31M2026-07-31: -$34.90M-$34.90M
2021-07-31 Net Income (USD) 2026-07-31
Period endedNet IncomeChange YoYSource filing
2026-07-31-$34.90Mn/m2026-10-28, From 2025-08-01
2025-07-31-$26.31Mn/m2026-10-28, From 2024-08-01
2024-07-31-$4.79Mn/m2025-10-16, From 2023-08-01
2023-07-31-$20.30Mn/m2024-10-29, From 2022-08-01
2022-07-31-$26.84Mn/m2023-10-25, From 2021-08-01
2021-07-31-$13.82Mn/a2022-10-28, From 2020-08-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
BriaCell Therapeutics Corp. (BCTX)2026-07-31-$34.90Mn/m
Immunic, Inc. (IMUX)2025-12-31-$97.17Mn/m
Rein Therapeutics, Inc. (RNTX)2025-12-31-$49.87Mn/m
Kiora Pharmaceuticals Inc (KPRX)2025-12-31-$10.84Mn/m
Faeth Therapeutics, Inc. (FTH)2025-12-31-$21.09Mn/m
CervoMed Inc. (CRVO)2025-12-31-$26.97Mn/m
Gain Therapeutics, Inc. (GANX)2025-12-31-$20.16Mn/m
HCW Biologics Inc. (HCWB)2025-12-31-$7.96Mn/m
Onconetix, Inc. (ONCO)2025-12-31-$14.03Mn/m

Compare BCTX, IMUX, RNTX, KPRX side by side · Screen every company in Pharmaceutical Preparations ↗